Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
about
SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin.Impact of inclusion of industry trial results registries as an information source for systematic reviews.Acute and chronic impact of cardiovascular events on health state utilities.Ezetimibe-Statin Combination Therapy.Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis.Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in TaiwanEconomic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessmentCost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial.Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials.Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis.Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study.
P2860
Q35087116-35EA54E5-C827-4DC1-AB3E-11292D7CF6FCQ35151458-DEF95AC5-7CE6-4F6A-8E7F-77B9D9E540EEQ35534337-2BE28A87-F6DC-44E7-9FD6-6EC29CF68C88Q36076916-77AEC4D6-BE88-423B-8720-8870D5C6D7E1Q36952494-67FD8862-0F33-43CA-9D31-79BEAEB3C48CQ36981183-D1DE45FA-8DD4-4AA3-A953-1DEB3CD596C2Q37301010-28C348AA-D716-4601-8CE4-C4E4FE9AAA68Q37312285-2AB3A956-054E-4E5C-B629-CB776A78CD12Q37367505-0AC788C8-382D-4A90-97B5-D082E04F6A36Q37701839-08B1EA30-CECF-46E2-AA81-D901637BAA92Q37794308-69E5F5BB-1711-4F23-91BB-1527D0DAAC59Q40009334-D23C6B21-8434-42D5-AB2B-8FC90764A5FBQ41438653-FE89CEB6-57D4-4B6E-80F2-DCE442DC51DBQ43058509-8631AFB7-2E07-4CD8-91F7-614DE3B14903Q47392228-5B8E5260-BD7F-421C-AD71-0A058284D44BQ47624902-227F85A9-D917-4A11-9BDC-103B9D403DBA
P2860
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ezetimibe for the treatment of ...... eview and economic evaluation.
@en
Ezetimibe for the treatment of ...... eview and economic evaluation.
@nl
type
label
Ezetimibe for the treatment of ...... eview and economic evaluation.
@en
Ezetimibe for the treatment of ...... eview and economic evaluation.
@nl
prefLabel
Ezetimibe for the treatment of ...... eview and economic evaluation.
@en
Ezetimibe for the treatment of ...... eview and economic evaluation.
@nl
P2093
P356
P1476
Ezetimibe for the treatment of ...... eview and economic evaluation.
@en
P2093
Chilcott J
Wilkinson A
Williams R
P304
iii, xi-xiii, 1-212
P356
10.3310/HTA12210
P577
2008-05-01T00:00:00Z